New combo therapy shows promise against tough pancreatic cancer
Disease control
Completed
This study tested adding an experimental immune-boosting drug called indoximod to standard chemotherapy for people with pancreatic cancer that has spread to other parts of the body. The goal was to find the safest dose and see if the combination helps patients live longer. A tota…
Phase: PHASE1, PHASE2 • Sponsor: NewLink Genetics Corporation • Aim: Disease control
Last updated May 13, 2026 16:02 UTC